| 104737-2 |
Human metapneumovirus RNA |
PrThr |
XXX |
Pt |
Ord |
Molgen |
|
ACTIVE |
Human metapneumovirus RNA [Presence] in Specimen by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
104737-2 |
|
Molgen |
|
|
Observation |
|
|
|
0 |
hMPV RNA Spec Ql |
|
|
|
N |
|
hMPV; Microbiology; Misc; Miscellaneous; Molecular genetics; Ordinal; Other; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; Spec; To be specified in another part of the message; Unspecified |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 104738-0 |
Hemoglobin.gastrointestinal.lower |
PrThr |
Stool |
Pt |
Ord |
|
|
ACTIVE |
Hemoglobin.gastrointestinal.lower [Presence] in Stool |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HEM/BC |
|
104738-0 |
|
|
|
|
Observation |
|
|
|
0 |
Hemoccult Stl Ql |
|
|
|
N |
|
Bowel movement; Faecal; Faeces; Fecal; Fecal occult blood; Feces; FIT; FOB; FOBT; Gastrocult; Gastrointest blood; GI; Guiac; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hemoccult; Hemocult; Hgb; iFOBT; Low; Occult blood; Occult blood in stool; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Stl; Stool = Fecal |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 104739-8 |
Protein pattern |
Imp |
Urine |
Pt |
Nar |
|
|
ACTIVE |
Protein Fractions [Interpretation] in Urine Narrative |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
104739-8 |
|
|
|
|
Observation |
|
|
|
0 |
Prot Pattern Ur-Imp |
|
|
|
N |
|
Chemistry; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Point in time; PR; Prot; Prot Pattern; Protein fractions; Random; Report; UA; UR; Urn |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 10474-5 |
Collagen type 4 Ag |
PrThr |
Tiss |
Pt |
Ord |
Immune stain |
|
ACTIVE |
Collagen type 4 Ag [Presence] in Tissue by Immune stain |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATH |
|
10474-5 |
|
Immune stain |
|
|
Both |
|
|
|
0 |
Collagen4 Ag Tiss Ql ImStn |
|
|
|
|
|
Antigen; Antigens; Collagen type IV; Collagen4; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Ordinal; PATHOLOGY; Point in time; PR; QL; Qual; Qualitative; Random; Screen; St; Stains; Stn; Tissue; Tissue, unspecified |
2.73 |
1.0i |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 104740-6 |
Prostate cancer risk |
Likelihood |
^Patient |
Pt |
Qn |
|
|
ACTIVE |
Prostate cancer risk [Likelihood] |
|
ADD |
DefinitionDescription |
|
|
risk |
|
|
|
|
|
|
CHEM |
|
104740-6 |
|
|
|
|
Observation |
|
|
|
0 |
Prostate cancer risk Patient |
|
|
|
N |
|
Chemistry; Point in time; QNT; Quan; Quant; Quantitative; Random; Risk |
2.78 |
2.78 |
|
|
|
|
|
|
|
{risk} |
|
|
|
0 |
| 104741-4 |
Hepatitis C virus Ab Signal/Cutoff |
RelACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma |
|
ADD |
DefinitionDescription |
|
|
ratio |
|
|
|
|
|
|
MICRO |
|
104741-4 |
|
|
|
|
Observation |
|
|
|
0 |
HCV Ab s/co SerPl |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; co; cut off; HCV; HCV Ab s/co; HCV Ab Signal; HCVAB; Hep; Hep C; Hepatis; Hepatit; Microbiology; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; RlACnc; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.78 |
2.78 |
|
|
|
|
|
|
|
{ratio} |
|
|
|
0 |
| 104742-2 |
Ova & parasites |
Prid |
XXX |
Pt |
Nom |
|
|
ACTIVE |
Ova and parasites identified in Specimen |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
104742-2 |
|
|
|
|
Observation |
|
|
|
0 |
O+P Spec |
|
|
|
N |
|
Identity or presence; Microbiology; Misc; Miscellaneous; Nominal; O&P; O+P; Other; Ova and parasite; Ovum; Parasite; Point in time; Random; Spec; To be specified in another part of the message; Unspecified |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 104743-0 |
Epstein Barr virus DNA |
NCnc |
XXX |
Pt |
Qn |
Molgen |
|
ACTIVE |
Epstein Barr virus DNA [#/volume] in Specimen by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
copies/mL |
|
|
|
|
|
|
MICRO |
|
104743-0 |
|
Molgen |
|
|
Observation |
|
|
|
0 |
EBV DNA # Spec |
|
|
|
N |
|
#; ABS; absolute; absolutes; Cnt; Count; Count/volume; CT; Deoxyribonucleic acid; EBV; Epstn; HHV-4; human herpesvirus 4; Microbiology; Misc; Miscellaneous; Molecular genetics; Mono; Mononucleosis; Number concentration; Number Concentration (count/vol); Other; PCR; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; To be specified in another part of the message; Unspecified |
2.78 |
2.78 |
|
|
|
|
|
|
|
{copies}/mL |
|
|
|
0 |
| 104744-8 |
Respiratory syncytial virus RNA |
PrThr |
XXX |
Pt |
Ord |
Molgen |
|
ACTIVE |
Respiratory syncytial virus RNA [Presence] in Specimen by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
104744-8 |
|
Molgen |
|
|
Observation |
|
|
|
0 |
RSV RNA Spec Ql |
|
|
|
N |
|
HRSV; Microbiology; Misc; Miscellaneous; Molecular genetics; Ordinal; Other; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Ribonucleic acid; RSV; Screen; Spec; To be specified in another part of the message; Unspecified |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 104745-5 |
N-nortramadol |
MCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
N-nortramadol [Mass/volume] in Urine |
|
ADD |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
104745-5 |
|
|
|
|
Observation |
|
|
|
0 |
N-nortramadol Ur-mCnc |
|
|
|
N |
|
Desmeth; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; N-desmethyltramadol; NDT; Notramadol; O-desmethyltramadol; ODT; Point in time; QNT; Quan; Quant; Quantitative; Random; Tramadol metabolite; UA; UR; Urn |
2.78 |
2.78 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 104746-3 |
Medication stop criteria |
Find |
^Patient |
Pt |
Nom |
|
|
ACTIVE |
Medication stop criteria |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MEDS |
|
104746-3 |
|
|
|
|
Observation |
|
|
|
0 |
Med stop criteria |
|
|
|
N |
|
Finding; Findings; Med stop criteria; MEDS; Nominal; Point in time; Random |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 104747-1 |
Medication purpose |
Find |
^Patient |
Pt |
Nar |
|
|
ACTIVE |
Medication purpose Narrative |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MEDS |
|
104747-1 |
|
|
|
|
Observation |
|
|
|
0 |
Medication purpose |
|
|
|
N |
|
Finding; Findings; MEDS; Narrative; Point in time; Random; Report |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 104748-9 |
Medication order stop |
Date |
^Patient |
Pt |
Qn |
|
|
ACTIVE |
Medication order stop [Date] |
|
ADD |
DefinitionDescription |
|
|
MMDDYY |
|
|
|
|
|
|
MEDS |
|
104748-9 |
|
|
|
|
Observation |
|
|
|
0 |
Med order stop |
|
|
|
N |
|
Med order stop; MEDS; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.78 |
2.78 |
|
|
|
|
|
|
|
{mm/dd/yyyy} |
|
|
|
0 |
| 104749-7 |
Review criteria |
Find |
^Patient |
Pt |
Nar |
|
|
ACTIVE |
Review criteria Narrative |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MEDS |
|
104749-7 |
|
|
|
|
Observation |
|
|
|
0 |
Review criteria |
|
|
|
N |
|
Finding; Findings; MEDS; Narrative; Point in time; Random; Report |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 10475-2 |
Corticotropin Ag |
PrThr |
Tiss |
Pt |
Ord |
Immune stain |
|
ACTIVE |
Corticotropin Ag [Presence] in Tissue by Immune stain |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATH |
|
10475-2 |
|
Immune stain |
|
|
Both |
|
|
|
0 |
ACTH Ag Tiss Ql ImStn |
|
|
|
|
|
ACTH; Adrenocorticotrophic hormone; Adrenocorticotropin; Antigen; Antigens; c206; c74; Cortrosyn; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Ordinal; PATHOLOGY; Point in time; PR; QL; Qual; Qualitative; Random; Rc206; Screen; St; Stains; Stn; Tissue; Tissue, unspecified; Tumor marker |
2.73 |
1.0i |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 104750-5 |
Ovalocytes |
PrThr |
Bld |
Pt |
Ord |
|
|
ACTIVE |
Ovalocytes [Presence] in Blood |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HEM/BC |
|
104750-5 |
|
|
|
|
Observation |
|
|
|
0 |
Ovalocytes Bld Ql |
|
|
|
N |
|
Blood; HEMATOLOGY/CELL COUNTS; Ordinal; Ovalocyte; Ovalos; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 104751-3 |
Smudge cells |
PrThr |
Bld |
Pt |
Ord |
|
|
ACTIVE |
Smudge cells [Presence] in Blood |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HEM/BC |
|
104751-3 |
|
|
|
|
Observation |
|
|
|
0 |
Smudge Cells Bld Ql |
|
|
|
N |
|
Basket cells; Blood; Cell; Cellularity; HEMATOLOGY/CELL COUNTS; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 104752-1 |
Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA |
PrThr |
Cvx |
Pt |
Ord |
Molgen |
|
ACTIVE |
Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA [Presence] in Cervix by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
104752-1 |
|
Molgen |
|
|
Both |
|
|
|
0 |
HPV I/H Risk 1 DNA Cvx Ql |
|
|
|
N |
|
Cervix; Deoxyribonucleic acid; Genital tract; Genital warts; HPV; HPV I/H Risk 1; HPV IHR; HPV16; HPV16 and 18; HPV16+18; Human papillomavirus; Microbiology; Molecular genetics; Ordinal; Papilloma virus high risk; Papilloma virus intermediate/high risk; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Screen |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 104753-9 |
Burr cells |
PrThr |
Bld |
Pt |
Ord |
|
|
ACTIVE |
Burr cells [Presence] in Blood |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HEM/BC |
|
104753-9 |
|
|
|
|
Observation |
|
|
|
0 |
Burr Cells Bld Ql |
|
|
|
N |
|
Blood; Cell; Cellularity; Echinocyte; Echinocytes; Erythrocytes.crenated; HEMATOLOGY/CELL COUNTS; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Sea urchin cells; WB; Whole blood |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 104754-7 |
Polychromasia |
PrThr |
Bld |
Pt |
Ord |
|
|
ACTIVE |
Polychromasia [Presence] in Blood |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HEM/BC |
|
104754-7 |
|
|
|
|
Observation |
|
|
|
0 |
Polychromasia Bld Ql |
|
|
|
N |
|
Blood; HEMATOLOGY/CELL COUNTS; Ordinal; Point in time; Polychro; Polychromatophilia; Polychromic; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 104755-4 |
Hepatitis C virus RNA |
LnCnc |
Ser/Plas |
Pt |
Qn |
Molgen |
|
ACTIVE |
Hepatitis C virus RNA [Log #/volume] in Serum or Plasma by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
Log cells/mL |
|
|
|
|
|
|
MICRO |
|
104755-4 |
|
Molgen |
|
|
Observation |
|
|
|
0 |
HCV RNA SerPl-Log# |
|
|
|
N |
|
HCV; Hep; Hep C; Hepatis; Hepatit; Log NCNC; Log#; Microbiology; Molecular genetics; PCR; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.78 |
2.78 |
|
|
|
|
|
|
|
{Log_cells}/mL |
|
|
|
0 |
| 104756-2 |
Order identifier |
ID |
^Patient |
Pt |
Nom |
|
|
ACTIVE |
Order identifier |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CLIN |
|
104756-2 |
|
|
|
|
Observation |
|
|
|
0 |
Order ID |
|
|
|
N |
|
CLIN; Ident; Identifier; Nominal; Point in time; Random |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 104757-0 |
Staphylococcus aureus DNA |
PrThr |
XXX |
Pt |
Ord |
Molgen |
|
ACTIVE |
Staphylococcus aureus DNA [Presence] in Specimen by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
104757-0 |
|
Molgen |
|
|
Both |
|
|
|
0 |
S aureus DNA Spec Ql |
|
|
|
N |
|
Deoxyribonucleic acid; Microbiology; Misc; Miscellaneous; Molecular genetics; o71; Ordinal; Other; PCR; Point in time; PR; QL; Qual; Qualitative; Random; S aureus; Screen; Spec; Staph; To be specified in another part of the message; Unspecified |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 104758-8 |
Gardnerella vaginalis DNA |
PrThr |
Vag |
Pt |
Ord |
Molgen |
|
ACTIVE |
Gardnerella vaginalis DNA [Presence] in Vaginal fluid by Molecular genetics method |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
104758-8 |
|
Molgen |
|
|
Observation |
|
|
|
0 |
G vaginalis DNA Vag Ql |
|
|
|
N |
|
Deoxyribonucleic acid; G vaginalis; Genital vaginal; Microbiology; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Vag fld; Vag fluid; Vagina; Vaginal fluid |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 104759-6 |
Dohle body |
PrThr |
Bld |
Pt |
Ord |
|
|
ACTIVE |
Dohle body [Presence] in Blood |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HEM/BC |
|
104759-6 |
|
|
|
|
Observation |
|
|
|
0 |
Dohle Bod Bld Ql |
|
|
|
N |
|
Blood; bod; Bodies; HEMATOLOGY/CELL COUNTS; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood |
2.78 |
2.78 |
|
|
|
|
|
|
|
|
|
|
|
0 |
